# US 2010/0251393 A1 · Transgenic animals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0251393 A1
- Document ID: US20100251393A1
- Status: Published application
- Kind: A1
- Application number: 12/641,847
- Filed: 2009-12-18
- Published: 2010-09-30
- Earliest claimed: 2006-05-24
- Assignees: North Carolina State University
- Inventors: Paul E. Mozdziak; James N. Petitte
- Web page: https://patentgrep.com/patent/US20100251393A1

## CPC

- A01K 67/0275: Genetically modified vertebrates, e.g. transgenic
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 15/8509: {for producing genetically modified animals, e.g. transgenic}
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- A01K 2227/00: Animals characterised by species
- A01K 2267/03: Animal model, e.g. for test or diseases
- C12N 2799/027: where the vector is derived from a retrovirus
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A transgenic animal such as a transgenic snake or other reptile that expresses a heterologous expression product is described, along with methods of making the same. In general, the animal comprises cells containing a sequence encoding the heterologous expression product. The sequence encoding the heterologous expression product is integrated into the genome of the animal (e.g., in some or all cells thereof, and in some embodiments into germ cells thereof). The sequence encoding the heterologous expression product is, in general, operatively associated with an expression sequence or promoter. The animals are useful for, among other things, testing of repellents, testing of toxicological compounds, as teaching aids, for venom production, etc.

## Claims

### Claim 1

A transgenic reptile that expresses a heterologous expression product, comprising cells containing an expression sequence operably linked to a sequence encoding said heterologous expression product, wherein the sequence encoding the expression product is integrated into the genome of the reptile.

### Claim 2 (depends on 1)

The transgenic reptile of claim 1, wherein said expression product is a reporter protein.

### Claim 3 (depends on 1)

The transgenic reptile of claim 1, wherein said expression product is a fluorescent or luminescent protein.

### Claim 4 (depends on 1)

The transgenic reptile of claim 1, wherein said reptile has a phenotype of fluorescence or luminescence not found in the corresponding wild-type reptile.

### Claim 5 (depends on 1)

The transgenic reptile of claim 1, wherein said expression product is a therapeutic protein.

### Claim 6 (depends on 1)

The transgenic reptile of claim 1, wherein said reptile is selected from the group consisting of snakes, lizards, turtles, tortoises, and crocodilians.

### Claim 7 (depends on 1)

The transgenic reptile of claim 1, wherein expression of the expression product is stable and transmitted through the germline thereof.

### Claim 8 (depends on 1)

The transgenic reptile of claim 1, wherein said expression product is expressed in skin, skeletal muscle or both.

### Claim 9

A transgenic reptile that expresses a heterologous expression product, comprising cells containing an expression sequence operably linked to a sequence encoding said heterologous expression product, wherein the sequence encoding the expression product is integrated into the genome of the reptile;
wherein said expression product is a fluorescent or luminescent protein and said reptile has a phenotype of fluorescence or luminescence not found in the corresponding wild-type reptile;
and wherein said reptile is selected from the group consisting of snakes, lizards, turtles, tortoises, and crocodilians.

### Claim 10 (depends on 9)

The transgenic reptile of claim 9, wherein said expression product is expressed in skin, skeletal muscle or both.

### Claim 11 (depends on 9)

The transgenic reptile of claim 9, wherein expression of the expression product is stable and transmitted through the germline thereof.

### Claim 12 (depends on 9)

A method of screening a compound or composition for reptile repellent activity, comprising applying a candidate compound or composition to a target and then observing the behavior of reptile according to claim 9 in relation to said target, wherein avoidance of said target by said reptile indicates said compound or composition has reptile repellent activity.

### Claim 13

A transgenic snake that expresses a heterologous expression product, comprising an expression sequence operably linked to a sequence encoding said heterologous expression product, wherein the sequence encoding the expression product is integrated into the genome of the snake.

### Claim 14 (depends on 13)

The transgenic snake of claim 13, wherein said expression product is a reporter protein.

### Claim 15 (depends on 13)

The transgenic snake of claim 13, wherein said expression product is a fluorescent or luminescent protein.

### Claim 16 (depends on 13)

The transgenic snake of claim 13, wherein said snake has a phenotype of fluorescence or luminescence not found in the corresponding wild-type snake.

### Claim 17 (depends on 13)

The transgenic snake of claim 13, wherein said expression product is a therapeutic protein.

### Claim 18 (depends on 13)

The transgenic snake of claim 13, wherein expression of the expression product is stable and transmitted through the germline thereof.

### Claim 19 (depends on 13)

The transgenic snake of claim 13, wherein said expression product is expressed in skin, skeletal muscle or both.

### Claim 20

A transgenic snake that expresses a heterologous expression product, comprising an expression sequence operably linked to a sequence encoding said heterologous expression product, wherein the sequence encoding the expression product is integrated into the genome of the snake;
wherein said expression product is a fluorescent or luminescent protein and said snake has a phenotype of fluorescence or luminescence not found in the corresponding wild-type snake;
and wherein said snake is a corn snake, ball python, or Kingsnake.

### Claim 21 (depends on 20)

The transgenic snake of claim 20, wherein said expression product is expressed in skin, skeletal muscle or both.

### Claim 22 (depends on 20)

The transgenic snake of claim 20, wherein expression of the expression product is stable and transmitted through the germline thereof.

### Claim 23 (depends on 20)

The transgenic snake of claim 20, wherein said snake is an albino or leucistic snake.

### Claim 24 (depends on 21)

A method of screening a compound or composition for snake repellent activity, comprising applying a candidate compound or composition to a target and then observing the behavior of snake according to claim 21 in relation to said target, wherein avoidance of said target by said snake indicates said compound or composition has snake repellent activity.

### Claim 25

A method of making a transgenic reptile, comprising the steps of:
(a) providing an expression sequence operably linked to a sequence encoding a heterologous expression product,
(b) transforming a reptile in ovo with said expression sequence so that the sequence encoding the expression product is integrated into the genome of the snake, and then
(c) incubating said snake to hatch to produce a chimeric first generation snake.

### Claim 26 (depends on 25)

The method of claim 25, wherein said expression product is a reporter protein or therapeutic protein

### Claim 27 (depends on 25)

The method of claim 25, wherein said expression product is a fluorescent or luminescent protein and said chimeric first generation snake has a phenotype of fluorescence or luminescence not found in the corresponding wild-type reptile.

### Claim 28 (depends on 27)

The method of claim 27, wherein germ cells of said chimeric first generation reptile include said expression sequence integrated therein, said method further comprising the steps of
(d) crossing said chimeric first generation reptile with a leucistic or albino reptile of the same species to produce a second generation reptile; said second generation reptile having both (i) said leucistic or albino phenotype and (ii) a phenotype of fluorescence or luminescence not found in the corresponding wild-type reptile.

### Claim 29 (depends on 28)

The method of claim 28, wherein said reptile is a snake.
